“To help address this global challenge, we have
increased our manufacturing capacity and output of equipment – including
CTs, ultrasound devices, mobile X-ray systems, patient monitors and
ventilators – important in the diagnosis and treatment of COVID-19
patients, while taking steps to ensure safe operations for our
employees,” says GE Healthcare (NYSE:GE) CEO Kieran Murphy.
“As the global pandemic evolves, there is
unprecedented demand for medical equipment, including ventilators. We
continue to explore all options to support this increased need.”
GE -2% premarket to $6.47/share.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.